Michele Simbolo

19.1k total citations
64 papers, 1.5k citations indexed

About

Michele Simbolo is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michele Simbolo has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 20 papers in Epidemiology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michele Simbolo's work include Neuroendocrine Tumor Research Advances (16 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Lung Cancer Research Studies (14 papers). Michele Simbolo is often cited by papers focused on Neuroendocrine Tumor Research Advances (16 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Lung Cancer Research Studies (14 papers). Michele Simbolo collaborates with scholars based in Italy, United States and Switzerland. Michele Simbolo's co-authors include Aldo Scarpa, Andrea Mafficini, Rita T. Lawlor, Matteo Fassan, Vincenzo Corbo, Giampaolo Tortora, Emilio Bria, Giorgio Malpeli, Claudio Luchini and Caterina Vicentini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Michele Simbolo

58 papers receiving 1.5k citations

Peers

Countries citing papers authored by Michele Simbolo

Since Specialization

Citations

This map shows the geographic impact of Michele Simbolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Simbolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Simbolo more than expected).

Fields of papers citing papers by Michele Simbolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Simbolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Simbolo. The network helps show where Michele Simbolo may publish in the future.

Co-authorship network of co-authors of Michele Simbolo

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Simbolo. A scholar is included among the top collaborators of Michele Simbolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Simbolo. Michele Simbolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 2025 ·Lung Cancer ·(unknown), (unknown), Michele Simbolo, Alessandra Cocomazzi, Maria Liliana Piredda, Anna Caliò, (unknown), (unknown), Nicola Veronese, Alice Avancini, Fabrizio Zanconati, Michèle Milella, Aldo Scarpa, Sara Pilotto, Lorenzo Belluomini, Claudio Luchini	0
2	Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms 2024 ·British Journal of Cancer ·Valentina Angerilli, Giovanna Sabella, Michele Simbolo, (unknown), Giovanni Centonze, Marco Gentili, Alessandro Mangogna, Jorgelina Coppa, Giada Munari, Gianluca Businello, Chiara Borga, Francesca Schiavi, Sara Pusceddu, Rita Leporati, (unknown), Matteo Fassan, Massimo Milione	7
3	Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (CROCC) Alterations 2023 ·Genes ·Andrea Remo, Federica Grillo, Luca Mastracci, Michele Simbolo, Matteo Fassan, Maria Paola Cecchini, Giuseppe Miscio, Antonio Sassano, Paola Parente, Alessandro Vanoli, Giovanna Sabella, Guido Giordano, Emanuele Damiano Luca Urso, Luigi Cerulo, Aldo Scarpa, Francesco Fiorica, Massimo Pancione	2
4	An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide 2023 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), Αναστάσιος Γκουντάκος, Aldo Scarpa, Michele Simbolo	13
5	Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment 2023 ·Cancers ·Αναστάσιος Γκουντάκος, (unknown), Nicola Silvestris, (unknown), Mario De Bellis, Laura Alaimo, (unknown), (unknown), Aldo Mombello, Michele Simbolo, (unknown), Michèle Milella, Matteo Fassan, Aldo Scarpa, Claudio Luchini	8
6	Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance 2022 ·Biomedicines ·Αναστάσιος Γκουντάκος, Giovanni Centonze, Emanuele Vita, Lorenzo Belluomini, Michèle Milella, Emilio Bria, Massimo Milione, Aldo Scarpa, Michele Simbolo	10
7	Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology 2022 ·International Journal of Molecular Sciences ·Αναστάσιος Γκουντάκος, Michele Simbolo, (unknown), Aldo Scarpa, Claudio Luchini	5
8	pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 2022 ·Histopathology ·Valeria Barresi, Michele Simbolo, (unknown), Serena Pedron, Andrea Mafficini, Aldo Scarpa	0
9	Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentric Series 2022 ·Current Oncology ·Serena Ammendola, Michele Simbolo, (unknown), (unknown), Maria Caffo, Giampietro Pinna, Francesco Sala, Aldo Scarpa, Valeria Barresi	4
10	Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades 2021 ·Cancers ·Michele Simbolo, (unknown), Andrea Mafficini, Claudio Luchini, Daniela Furlan, Frediano Inzani, Gianluigi Petrone, (unknown), Stefano La Rosa, Giovanni Schinzari, Antonio Bianchi, Ernesto Rossi, Roberta Menghi, Felice Giuliante, Stefania Boccia, Aldo Scarpa, Guido Rindi	18
11	Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival 2021 ·Cancers ·Valeria Barresi, Michele Simbolo, (unknown), Maria Liliana Piredda, Maria Caffo, Claudio Ghimenton, Giampietro Pinna, Michele Longhi, A. Nicolato, Aldo Scarpa	25
12	Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 2021 ·Cells ·Lorenzo Belluomini, (unknown), Michele Simbolo, Riccardo Nocini, Ilaria Trestini, Alice Avancini, Daniela Tregnago, Miriam Grazia Ferrara, (unknown), (unknown), Anna Caliò, Emilio Bria, Aldo Scarpa, Michèle Milella, Jessica Menis, Sara Pilotto	4
13	Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 2021 ·Diagnostics ·Elisa Baratella, Barbara Ruaro, Fabiola Giudici, Barbara Wade, (unknown), Francesco Salton, Paola Confalonieri, Michele Simbolo, Aldo Scarpa, (unknown), Cristina Marrocchio, Maria Assunta Cova, Marco Confalonieri	50
14	Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 2021 ·Journal of Clinical Medicine ·Giovanni Centonze, (unknown), Giovanna Sabella, Alessandro Mangogna, (unknown), (unknown), Beatrice Belmonte, Laura Cattaneo, (unknown), Alessio Pellegrinelli, Michele Simbolo, Aldo Scarpa, Paola Spaggiari, (unknown), Sara Pusceddu, Natalie Prinzi, Andrea Anichini, Claudio Tripodo, Massimo Milione	7
15	Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 2019 ·Scientific Reports ·Dea Filippini, (unknown), Pietro Delfino, Michele Simbolo, Geny Piro, Borislav C. Rusev, (unknown), Cinzia Cantù, (unknown), Stefano Ugel, Francesco De Sanctis, Vincenzo Bronte, Michèle Milella, Giampaolo Tortora, Aldo Scarpa, Carmine Carbone, Vincenzo Corbo	24
16	Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 2019 ·Cancers ·Valeria Barresi, Michele Simbolo, Andrea Mafficini, Maria Liliana Piredda, Maria Caffo, Salvatore Cardali, Antonino Germanò, Sara Cingarlini, Claudio Ghimenton, Aldo Scarpa	23
17	Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 2018 ·Scientific Reports ·Michele Simbolo, Caterina Vicentini, Andrea Ruzzenente, Matteo Brunelli, Simone Conci, Matteo Fassan, Andrea Mafficini, Borislav C. Rusev, Vincenzo Corbo, Paola Capelli, Emilio Bria, Serena Pedron, Giona Turri, Rita T. Lawlor, Giampaolo Tortora, Claudio Bassi, Alfredo Guglielmi, Aldo Scarpa	36
18	ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 2018 ·Pathology - Research and Practice ·Caterina Vicentini, Cinzia Cantù, Davide Antonello, Michele Simbolo, Andrea Mafficini, Claudio Luchini, Borislav C. Rusev, Antonio Benito Porcaro, Roberto Iacovelli, Matteo Fassan, Vincenzo Corbo, Matteo Brunelli, Walter Artibani, Aldo Scarpa, Rita T. Lawlor	2
19	Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Michele Simbolo, Caterina Vicentini, Andrea Mafficini, Matteo Fassan, Serena Pedron, Vincenzo Corbo, Luca Mastracci, Borislav C. Rusev, Corrado Pedrazzani, Luca Landoni, Federica Grillo, Sara Cingarlini, Guido Rindi, Claudio Luchini, Aldo Scarpa, Rita T. Lawlor	37
20	A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics 2015 ·Cancer Discovery ·Anguraj Sadanandam, Stephan Wullschleger, Costas A. Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, (unknown), (unknown), Andrea Mafficini, Rita T. Lawlor, Michele Simbolo, John M. Asara, Hendrik Bläker, Lewis C. Cantley, Bertram Wiedenmann, Aldo Scarpa, Douglas Hanahan	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact